Immune-mediated diseases associated with cancer risks
JAMA Dec 08, 2021
He MM, Lo CH, Wang K, et al. - In this study, immune-mediated diseases were found to be linked with risk of cancer at the local and systemic levels. Observations lend support to the role of local and systemic immunoregulation in carcinogenesis.
This is a cohort study of 478,753 participants (mean [SD] age, 56.4 [8.1] years; 54% female) from the UK Biobank cohort study.
Cancer cases, over 4,600,460 person-years of follow-up, were 2,834 and 26,817 in patients with (n= 61,496) and without (n=417,257) immune-mediated diseases (multivariable hazard ratio, 1.08).
Immune-mediated diseases were related to an elevated risk of total cancer.
Organ-specific immune-mediated diseases showed stronger links with risk of local cancers vs extralocal cancers.
The links for individual immune-mediated diseases were identified to be largely organ specific but were also noted for some malignancies in the near and distant organs or different systems.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries